e-learning
resources
Virtual 2020
Pre-Congress Content
Multidrug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
K. Glebov (Moscow, Russian Federation), A. Russkikh (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation), Y. Timakova (Moscow, Russian Federation)
Source:
Virtual Congress 2020 – Multidrug-resistant tuberculosis
Session:
Multidrug-resistant tuberculosis
Session type:
E-poster session
Number:
1606
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Glebov (Moscow, Russian Federation), A. Russkikh (Moscow, Russian Federation), A. Samoilova (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation), Y. Timakova (Moscow, Russian Federation). Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.. 1606
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005
Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan
Source: International Congress 2019 – Drug-resistant tuberculosis
Year: 2019
Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST.
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
Microbiology of
Mycobacterium tuberculosis
and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012
Clinical and operational value of the extensively drug-resistant tuberculosis definition
Source: Eur Respir J 2007; 30: 623-626
Year: 2007
In vitro susceptibility testing and totally drug-resistant tuberculosis
Source: Eur Respir J 2013; 42: 292
Year: 2013
In vitro susceptibility testing and totally drug-resistant tuberculosis
Source: Eur Respir J 2013; 42: 291-292
Year: 2013
The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
A standardised method for interpreting the association between mutations and phenotypic drug resistance in
Mycobacterium tuberculosis
Source: Eur Respir J, 50 (6) 1701354; 10.1183/13993003.01354-2017
Year: 2017
Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Genetic diversity of M. tuberculosis isolates from patients with drug-resistant TB in Japan
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018
Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Rapid detection of multi-drug-resistant tuberculosis (MDR-TB) in one day using the new molecular-biological test genotype MTBDRÔ
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006
The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis
Source: Eur Respir J 2012; 39: 626-634
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept